Title:
PHYSIOLOGICALLY FUNCTIONAL DRINKS AND COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2005/074960
Kind Code:
A1
Abstract:
The invention provides physiologically functional drinks and compositions which can prevent allergic rhinitis and are useful in the prevention and treatment of hyperlipemia and diseases derived therefrom such as arteriosclerosis, obesity, and liver diseases. The drinks and compositions contain as the preventive for allergic rhinitis or the antihyperlipemic agent methylated catechins represented by the general formula (1) in effective doses: wherein R1, R2, R3 and R4 are each independently hydrogen or methyl; and X1 and X2 are each independently hydrogen or hydroxy.
More Like This:
Inventors:
NAGAI HIROSHI (JP)
YASUE MASAAKI (JP)
YAMAMOTO MARI (JP)
YASUE MASAAKI (JP)
YAMAMOTO MARI (JP)
Application Number:
PCT/JP2005/001700
Publication Date:
August 18, 2005
Filing Date:
February 04, 2005
Export Citation:
Assignee:
ASAHI SOFT DRINKS CO LTD (JP)
ASAHI BREWERIES LTD (JP)
NAT AGRICULTURE & BIO ORIENTED RES ORG (JP)
NAGAI HIROSHI (JP)
YASUE MASAAKI (JP)
YAMAMOTO MARI (JP)
ASAHI BREWERIES LTD (JP)
NAT AGRICULTURE & BIO ORIENTED RES ORG (JP)
NAGAI HIROSHI (JP)
YASUE MASAAKI (JP)
YAMAMOTO MARI (JP)
International Classes:
A23F3/16; A23L1/30; A23L2/38; A23L2/52; A23L33/00; A61K8/49; A61K9/00; A61K31/353; A61K38/44; A61Q19/00; A61Q19/06; A61Q1/02; A61Q19/10; (IPC1-7): A61K35/78; A23F3/16; A23L2/38; A23L2/52; A61K7/00; A61K9/08; A61K31/353; A61P1/16; A61P3/06; A61P27/14; A61P27/16; A61P37/08; C07D311/62
Foreign References:
JP2001145456A | 2001-05-29 | |||
JPH11127781A | 1999-05-18 | |||
JPH07227210A | 1995-08-29 | |||
JPS6232842A | 1987-02-12 | |||
JPH011107A | ||||
JPH10234301A | 1998-09-08 | |||
JPH11146761A | 1999-06-02 | |||
JP2000159670A | 2000-06-13 | |||
JP2001253879A | 2001-09-18 | |||
JP2004105078A | 2004-04-08 |
Attorney, Agent or Firm:
Shobayashi, Masayuki (18-34 Minami-ikebukuro 3-chom, Toshima-ku Tokyo 22, JP)
Download PDF:
Previous Patent: USE OF AN EXTRACT OF PUERARIA TUBEROSA FOR THE TREATMENT OF DIABETES TYPE 2
Next Patent: BODY FAT-CONTROLLING AGENT
Next Patent: BODY FAT-CONTROLLING AGENT